Response to commentary on: A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's ranibizumab with Lucentis in patients with neovascular age-related macular degeneration

Bibliographic Details
Main Authors: Chirag Shah, Kishore Sonkusare
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Indian Journal of Ophthalmology
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=3;spage=1054;epage=1055;aulast=Shah